Carmustine [clinicaltrials_resource:2fc1c3e00c527f7090a2182e933d7480]
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002461]Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma [clinicaltrials:NCT00002556]O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors [clinicaltrials:NCT00002604]clinicaltrials:NCT00002835clinicaltrials:NCT00002836clinicaltrials:NCT00002941Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma [clinicaltrials:NCT00002988]Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma [clinicaltrials:NCT00003176]Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003346]Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain [clinicaltrials:NCT00003348]Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas [clinicaltrials:NCT00003463]Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma [clinicaltrials:NCT00003467]clinicaltrials:NCT00003567O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma [clinicaltrials:NCT00003613]clinicaltrials:NCT00003621O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors [clinicaltrials:NCT00003765]Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma [clinicaltrials:NCT00003876]Carmustine Implants in Treating Patients With Brain Metastases [clinicaltrials:NCT00003878]clinicaltrials:NCT00003996Carmustine in Treating Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00004028]clinicaltrials:NCT00004072Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00004079]Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [clinicaltrials:NCT00004688]O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00004892]clinicaltrials:NCT00005066Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma [clinicaltrials:NCT00005081]Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma [clinicaltrials:NCT00005637]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma [clinicaltrials:NCT00005855]O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma [clinicaltrials:NCT00005961]clinicaltrials:NCT00005981clinicaltrials:NCT00006386Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00006656]Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm [clinicaltrials:NCT00009854]Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer [clinicaltrials:NCT00014573]clinicaltrials:NCT00017147clinicaltrials:NCT00027612clinicaltrials:NCT00028665clinicaltrials:NCT00045721Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00046878]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Carmustine [clinicaltrials_resource:2fc1c3e00c527f7090a2182e933d7480]
Bio2RDF identifier
2fc1c3e00c527f7090a2182e933d7480
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2fc1c3e00c527f7090a2182e933d7480
identifier
clinicaltrials_resource:2fc1c3e00c527f7090a2182e933d7480
title
Carmustine
@en
type
label
Carmustine [clinicaltrials_resource:2fc1c3e00c527f7090a2182e933d7480]
@en